Corrigendum to “Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch” [Redox Biol. 52 (2022) 1–16/102311]

Detalles Bibliográficos
Autores principales: Ding, Mingge, Shi, Rui, Cheng, Shuli, Li, Man, De, Dema, Liu, Chaoyang, Gu, Xiaoming, Li, Juan, Zhang, Shumiao, Jia, Min, Fan, Rong, Pei, Jianming, Fu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108085/
https://www.ncbi.nlm.nih.gov/pubmed/35431146
http://dx.doi.org/10.1016/j.redox.2022.102315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108085/
https://www.ncbi.nlm.nih.gov/pubmed/35431146
http://dx.doi.org/10.1016/j.redox.2022.102315

Ejemplares similares